Table 9.
Compassion of outcomes between NSS COVID-19 patients and non-NSS COVID-19 patients
| Items | NSS patients (n=122) | Non-NSS patients (n=295) | P value |
|---|---|---|---|
| Time to nucleic acid negative (days), median (IQR) | 16.0 (11.3-24.0) | 14.0 (10.0-21.0) | 0.037 |
| Disease condition, No. (%) | |||
| Cured | 1 (0.8) | 2 (0.7) | 1.000 |
| Improved | 115 (94.3) | 285 (96.6) | 0.283 |
| Aggravated | 5 (4.1) | 6 (2.0) | 0.231 |
| Dead | 1 (0.8) | 2 (0.7) | 1.000 |
Comparison was determined by Wilcoxon rank sum test, Chi-square test or Fisher’s exact test. NSS, nervous system symptom; COVID-19, coronavirus disease 2019; IQR, interquartile range.